Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

healthcare information

Eyeforpharma – Real World Evidence 2018

16-17 May in Tokyo, Japan

Research Partnership

The rise of real-world evidence

Demonstrating efficacy and value requires more than clinical trial data

Roche Basel Switzerland

Roche to buy cancer data firm Flatiron for $1.9bn

Data provides a wealth of RWE opportunities

- PMLiVE

Prix Galien opens for entries with new award

2018 programme will include new medical technology category

- PMLiVE

Real-world evidence: It’s all in the approach

The merit of real-world evidence in the promotion and use of medicines is increasing and so too are the number of methodologies available

- PMLiVE

The reality of real-world evidence

Despite a slow uptake of RWE, there is an increasing trend in the use of healthcare system data to inform clinical practice

- PMLiVE

Managed Access Programmes: a powerful source of real-world insight

MAPs represent a unique opportunity to gather evidence from a cohort of patients receiving the same treatment, across multiple countries prospectively before launch

- PMLiVE

Real-world evidence

Companies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future

- PMLiVE

Merck forges cancer-focused big data alliance with Palantir

Plans to develop a collaborative analytics platform to accelerate research and improve outcomes

- PMLiVE

Real-world evidence

Investigating the sources of evidence as best practice moves from being knowledge-based to evidence-based

- PMLiVE

ApotheCom and Continuum Clinical expand strategic partnership

Team up to deliver real-world evidence-based integrated business solutions

- PMLiVE

Germany’s IQWIG ‘perplexed’ by EMA’s adaptive pathways plan

Reliance on real-world evidence questioned

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links